Aegerion Pharmaceuticals Inc (AEGR)

Track

Stock chart

Ticker: AEGR

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings

Earnings

Value bought

Past 90 days

Value sold

Past 90 days

Net insiders buying

Past 90 days

Trades (buy and sell)

Past 90 days

Company data

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2016-09-14	2016-09-13	B Purchase	Broadfin Healthcare Master Fund Ltd Large shareholder	75,000 +1.7% 1.75 USD 131,250	75,000 +1.7%	1.75	USD 131,250
2016-09-12	2016-09-12	B Purchase	Broadfin Healthcare Master Fund Ltd Large shareholder	76,000 +1.8% 1.70 USD 129,200	76,000 +1.8%	1.70	USD 129,200
2016-09-12	2016-09-12	B Purchase	Broadfin Healthcare Master Fund Ltd Large shareholder	100,000 +2.4% 1.70 USD 169,600	100,000 +2.4%	1.70	USD 169,600
2016-09-12	2016-09-09	B Purchase	Broadfin Healthcare Master Fund Ltd Large shareholder	100,000 +2.5% 1.60 USD 159,500	100,000 +2.5%	1.60	USD 159,500
2015-11-13	2015-11-11	B Purchase	Broadfin Healthcare Master Fund Ltd Large shareholder	35,000 +0.9% 10.96 USD 383,600	35,000 +0.9%	10.96	USD 383,600
2015-11-13	2015-11-11	B Purchase	Broadfin Healthcare Master Fund Ltd Large shareholder	5,100 +0.1% 10.99 USD 56,049	5,100 +0.1%	10.99	USD 56,049
2014-08-20	2014-08-19	B Purchase	Fitzpatrick Mark J. Chief Financial Officer Officer	1,150 +13.8% 30.64 USD 35,236	1,150 +13.8%	30.64	USD 35,236
2014-07-31	2014-07-31	B Purchase	Beer Marc D Chief Executive Officer Executive Director	2,300 +3.0% 34.37 USD 79,051	2,300 +3.0%	34.37	USD 79,051
2014-07-31	2014-07-31	B Purchase	Beer Marc D Chief Executive Officer Executive Director	7,700 +11.1% 33.44 USD 257,488	7,700 +11.1%	33.44	USD 257,488
2014-06-04	2014-06-03	B Purchase	Beer Marc D Chief Executive Officer Executive Director	10,000 +16.8% 30.12 USD 301,200	10,000 +16.8%	30.12	USD 301,200
2014-05-27	2014-05-27	B Purchase	Beer Marc D Chief Executive Officer Executive Director	10,000 +20.2% 31.59 USD 315,900	10,000 +20.2%	31.59	USD 315,900
2014-05-21	2014-05-20	B Purchase	Beer Marc D Chief Executive Officer Executive Director	10,000 +30.3% 30.53 USD 305,300	10,000 +30.3%	30.53	USD 305,300
2014-05-09	2014-05-08	B Purchase	VANLENT ANNE Non-Executive Director	52 +1.3% 35.29 USD 1,835	52 +1.3%	35.29	USD 1,835
2014-05-09	2014-05-08	B Purchase	VANLENT ANNE Non-Executive Director	1,948 +97.4% 34.33 USD 66,875	1,948 +97.4%	34.33	USD 66,875
2014-05-09	2014-05-08	B Purchase	VANLENT ANNE Non-Executive Director	2,000 +inf% 33.20 USD 66,400	2,000 +inf%	33.20	USD 66,400
2014-05-08	2014-05-08	B Purchase	Beer Marc D Chief Executive Officer Executive Director	30,000 +1000.0% 35.31 USD 1,059,300	30,000 +1000.0%	35.31	USD 1,059,300
2014-05-01	2014-04-30	PS Planned sale	Fraser Craig Pres., US/Int. Comm. & Manuf. Officer	1,171 -100.0% 43.90 USD 51,407	1,171 -100.0%	43.90	USD 51,407
2014-05-01	2014-04-30	PS Planned sale	Fraser Craig Pres., US/Int. Comm. & Manuf. Officer	1,079 -48.0% 43.18 USD 46,591	1,079 -48.0%	43.18	USD 46,591
2014-04-02	2014-03-31	PS Planned sale	Fraser Craig Pres., US/Int. Comm. & Manuf. Officer	100 -100.0% 47.20 USD 4,720	100 -100.0%	47.20	USD 4,720
2014-04-02	2014-03-31	PS Planned sale	Fraser Craig Pres., US/Int. Comm. & Manuf. Officer	1,001 -90.9% 46.51 USD 46,557	1,001 -90.9%	46.51	USD 46,557
2014-04-02	2014-03-31	PS Planned sale	Fraser Craig Pres., US/Int. Comm. & Manuf. Officer	1,149 -51.1% 45.84 USD 52,670	1,149 -51.1%	45.84	USD 52,670
2014-03-18	2014-03-14	PS Planned sale	Sumeray Mark Chief Medical Officer Officer	800 -100.0% 51.98 USD 41,584	800 -100.0%	51.98	USD 41,584
2014-03-18	2014-03-14	PS Planned sale	Sumeray Mark Chief Medical Officer Officer	900 -52.9% 51.31 USD 46,179	900 -52.9%	51.31	USD 46,179
2014-03-18	2014-03-14	PS Planned sale	Sumeray Mark Chief Medical Officer Officer	300 -15.0% 49.69 USD 14,907	300 -15.0%	49.69	USD 14,907
2014-02-18	2014-02-14	PS Planned sale	Sumeray Mark Chief Medical Officer Officer	500 -100.0% 64.52 USD 32,260	500 -100.0%	64.52	USD 32,260
2014-02-18	2014-02-14	PS Planned sale	Sumeray Mark Chief Medical Officer Officer	1,500 -75.0% 63.14 USD 94,710	1,500 -75.0%	63.14	USD 94,710
2014-02-12	2014-02-11	PS Planned sale	Fraser Craig Pres., US/Int. Comm. & Manuf. Officer	2,250 -100.0% 67.00 USD 150,750	2,250 -100.0%	67.00	USD 150,750
2014-02-12	2014-02-10	PS Planned sale	Fitzpatrick Mark J. Chief Financial Officer Officer	486 -7.7% 64.69 USD 31,439	486 -7.7%	64.69	USD 31,439
2014-02-12	2014-02-10	PS Planned sale	Fitzpatrick Mark J. Chief Financial Officer Officer	900 -12.4% 63.72 USD 57,348	900 -12.4%	63.72	USD 57,348
2014-02-12	2014-02-10	PS Planned sale	Fitzpatrick Mark J. Chief Financial Officer Officer	2,814 -28.0% 62.94 USD 177,113	2,814 -28.0%	62.94	USD 177,113
2014-02-12	2014-02-10	PS Planned sale	Fitzpatrick Mark J. Chief Financial Officer Officer	3,300 -24.7% 61.71 USD 203,643	3,300 -24.7%	61.71	USD 203,643
2014-01-21	2014-01-16	PS Planned sale	Sumeray Mark Chief Medical Officer Officer	100 -100.0% 59.51 USD 5,951	100 -100.0%	59.51	USD 5,951
2014-01-21	2014-01-16	PS Planned sale	Sumeray Mark Chief Medical Officer Officer	1,900 -95.0% 58.59 USD 111,318	1,900 -95.0%	58.59	USD 111,318
2014-01-06	2014-01-02	PS Planned sale	Sumeray Mark Chief Medical Officer Officer	600 -100.0% 71.41 USD 42,847	600 -100.0%	71.41	USD 42,847
2014-01-06	2014-01-02	PS Planned sale	Sumeray Mark Chief Medical Officer Officer	400 -40.0% 70.22 USD 28,087	400 -40.0%	70.22	USD 28,087
2014-01-06	2014-01-02	PS Planned sale	Fraser Craig Pres., US/Int. Comm. & Manuf. Officer	1,350 -100.0% 71.42 USD 96,414	1,350 -100.0%	71.42	USD 96,414
2014-01-06	2014-01-02	PS Planned sale	Fraser Craig Pres., US/Int. Comm. & Manuf. Officer	900 -40.0% 70.65 USD 63,584	900 -40.0%	70.65	USD 63,584
2013-12-17	2013-12-16	PS Planned sale	Sumeray Mark Chief Medical Officer Officer	200 -100.0% 67.38 USD 13,476	200 -100.0%	67.38	USD 13,476
2013-12-17	2013-12-16	PS Planned sale	Sumeray Mark Chief Medical Officer Officer	1,800 -90.0% 66.23 USD 119,211	1,800 -90.0%	66.23	USD 119,211
2013-12-04	2013-12-02	PS Planned sale	Fraser Craig Pres., US/Int. Comm. & Manuf. Officer	700 -100.0% 71.10 USD 49,769	700 -100.0%	71.10	USD 49,769
2013-12-04	2013-12-02	PS Planned sale	Fraser Craig Pres., US/Int. Comm. & Manuf. Officer	1,550 -68.9% 70.10 USD 108,654	1,550 -68.9%	70.10	USD 108,654
2013-12-04	2013-12-02	PS Planned sale	Sumeray Mark Chief Medical Officer Officer	600 -100.0% 71.20 USD 42,718	600 -100.0%	71.20	USD 42,718
2013-12-04	2013-12-02	PS Planned sale	Sumeray Mark Chief Medical Officer Officer	2,400 -80.0% 70.23 USD 168,549	2,400 -80.0%	70.23	USD 168,549
2013-11-19	2013-11-15	PS Planned sale	Sumeray Mark Chief Medical Officer Officer	500 -100.0% 77.63 USD 38,817	500 -100.0%	77.63	USD 38,817
2013-11-19	2013-11-15	PS Planned sale	Sumeray Mark Chief Medical Officer Officer	1,011 -66.9% 75.89 USD 76,726	1,011 -66.9%	75.89	USD 76,726
2013-11-19	2013-11-15	PS Planned sale	Sumeray Mark Chief Medical Officer Officer	489 -24.4% 74.93 USD 36,639	489 -24.4%	74.93	USD 36,639
2013-11-13	2013-11-11	PS Planned sale	Fitzpatrick Mark J. Chief Financial Officer Officer	1,800 -37.5% 80.03 USD 144,057	1,800 -37.5%	80.03	USD 144,057
2013-11-13	2013-11-11	PS Planned sale	Fitzpatrick Mark J. Chief Financial Officer Officer	4,478 -48.3% 79.34 USD 355,300	4,478 -48.3%	79.34	USD 355,300
2013-11-13	2013-11-11	PS Planned sale	Fitzpatrick Mark J. Chief Financial Officer Officer	622 -6.3% 78.38 USD 48,755	622 -6.3%	78.38	USD 48,755
2013-11-13	2013-11-11	PS Planned sale	Fitzpatrick Mark J. Chief Financial Officer Officer	200 -2.0% 76.14 USD 15,228	200 -2.0%	76.14	USD 15,228
2013-11-13	2013-11-11	PS Planned sale	Fitzpatrick Mark J. Chief Financial Officer Officer	200 -1.9% 74.43 USD 14,886	200 -1.9%	74.43	USD 14,886
2013-11-13	2013-11-11	PS Planned sale	Fitzpatrick Mark J. Chief Financial Officer Officer	200 -1.9% 73.01 USD 14,603	200 -1.9%	73.01	USD 14,603
2013-11-05	2013-11-01	PS Planned sale	Sumeray Mark Chief Medical Officer Officer	100 -100.0% 84.34 USD 8,434	100 -100.0%	84.34	USD 8,434
2013-11-05	2013-11-01	PS Planned sale	Sumeray Mark Chief Medical Officer Officer	2,000 -95.2% 83.59 USD 167,180	2,000 -95.2%	83.59	USD 167,180
2013-11-05	2013-11-01	PS Planned sale	Sumeray Mark Chief Medical Officer Officer	1,400 -40.0% 82.76 USD 115,867	1,400 -40.0%	82.76	USD 115,867
2013-11-05	2013-11-01	PS Planned sale	Fraser Craig Pres., US/Int. Comm. & Manuf. Officer	400 -100.0% 83.99 USD 33,597	400 -100.0%	83.99	USD 33,597
2013-11-05	2013-11-01	PS Planned sale	Fraser Craig Pres., US/Int. Comm. & Manuf. Officer	1,550 -79.5% 83.22 USD 128,994	1,550 -79.5%	83.22	USD 128,994
2013-11-05	2013-11-01	PS Planned sale	Fraser Craig Pres., US/Int. Comm. & Manuf. Officer	300 -13.3% 82.28 USD 24,684	300 -13.3%	82.28	USD 24,684
2013-11-05	2013-11-01	PS Planned sale	Carter Martha J. Chief Regulatory Officer & SVP Officer	5,000 -76.9% 82.81 USD 414,051	5,000 -76.9%	82.81	USD 414,051
2013-10-31	2013-10-30	PS Planned sale	Beer Marc D Chief Executive Officer Executive Director	1,200 -0.6% 99.18 USD 119,016	1,200 -0.6%	99.18	USD 119,016
2013-10-31	2013-10-30	PS Planned sale	Beer Marc D Chief Executive Officer Executive Director	300 -0.2% 95.90 USD 28,770	300 -0.2%	95.90	USD 28,770
2013-10-31	2013-10-30	PS Planned sale	Beer Marc D Chief Executive Officer Executive Director	200 -0.1% 94.25 USD 18,850	200 -0.1%	94.25	USD 18,850
2013-10-31	2013-10-30	PS Planned sale	Beer Marc D Chief Executive Officer Executive Director	400 -0.2% 93.00 USD 37,200	400 -0.2%	93.00	USD 37,200
2013-10-31	2013-10-30	PS Planned sale	Beer Marc D Chief Executive Officer Executive Director	700 -0.4% 92.03 USD 64,421	700 -0.4%	92.03	USD 64,421
2013-10-31	2013-10-30	PS Planned sale	Beer Marc D Chief Executive Officer Executive Director	2,500 -1.2% 91.21 USD 228,031	2,500 -1.2%	91.21	USD 228,031
2013-10-31	2013-10-30	PS Planned sale	Beer Marc D Chief Executive Officer Executive Director	2,700 -1.3% 89.85 USD 242,592	2,700 -1.3%	89.85	USD 242,592
2013-10-31	2013-10-30	PS Planned sale	Beer Marc D Chief Executive Officer Executive Director	3,800 -1.8% 89.01 USD 338,243	3,800 -1.8%	89.01	USD 338,243
2013-10-31	2013-10-30	PS Planned sale	Beer Marc D Chief Executive Officer Executive Director	6,019 -2.8% 87.83 USD 528,619	6,019 -2.8%	87.83	USD 528,619
2013-10-31	2013-10-30	PS Planned sale	Beer Marc D Chief Executive Officer Executive Director	10,000 -4.5% 87.08 USD 870,752	10,000 -4.5%	87.08	USD 870,752
2013-10-31	2013-10-30	PS Planned sale	Beer Marc D Chief Executive Officer Executive Director	2,314 -1.0% 85.94 USD 198,860	2,314 -1.0%	85.94	USD 198,860
2013-10-31	2013-10-30	PS Planned sale	Beer Marc D Chief Executive Officer Executive Director	7,067 -3.0% 85.00 USD 600,689	7,067 -3.0%	85.00	USD 600,689
2013-10-31	2013-10-30	PS Planned sale	Beer Marc D Chief Executive Officer Executive Director	2,800 -1.2% 84.15 USD 235,621	2,800 -1.2%	84.15	USD 235,621
2013-10-31	2013-10-29	PS Planned sale	SMITH SANDFORD D Non-Executive Director	2,502 -100.0% 95.00 USD 237,690	2,502 -100.0%	95.00	USD 237,690
2013-10-16	2013-10-15	PS Planned sale	Sumeray Mark Chief Medical Officer Officer	1,000 -100.0% 80.71 USD 80,709	1,000 -100.0%	80.71	USD 80,709
2013-10-16	2013-10-15	PS Planned sale	Sumeray Mark Chief Medical Officer Officer	1,000 -50.0% 79.95 USD 79,950	1,000 -50.0%	79.95	USD 79,950

Aegerion Pharmaceuticals Inc (AEGR)

Track

Stock chart

Earnings

Value bought

Value sold

Net insiders buying

Trades (buy and sell)

Transactions

Insider

Sort by